Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Why overcoming VEGF TKI resistance could reshape the treatment algorithm in clear cell renal cell carcinoma Can overcoming VEGF resistance reshape kidney cancer treatment? Explore what Kura Oncology’s latest data means for markets and strategy. bySoujanya RaviApril 19, 2026